Newsroom

ATLANTA--(BUSINESS WIRE)--Carter’s, Inc. (NYSE:CRI), North America’s largest and most-enduring apparel company exclusively for babies and young children, today announced preliminary net sales results for the fourth quarter and fiscal year 2025, participation at an upcoming investor conference, and an addition to the Company’s management team. Preliminary Net Sales Results Fourth Quarter Fiscal 2025 (14 Weeks) Compared to Fourth Quarter Fiscal 2024 (13 Weeks) On a preliminary, unaudited basis, f...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2025 (4Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on February 11, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 4Q25 earnings call may be accessed via Humana’s Investor Relations page...

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside Tamarac, located at 6001 N University Drive in Tamarac, Fla. It is the Company’s 31st dispensary in Florida and 72nd nationwide. “Florida is the largest medical market in the country, and opening Sunnyside Tamarac reinforces our long-term commitment to serving patients across the state,” said Charlie Bachtell, CEO of Cresco Labs. “We’re...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF- August 08.01.2026 GAUG LN IE000TGSG3Y5  650,002.00 USD  23,018,662.49   35.413  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Scarce Resources UCTS ETF 08.01.2026 SCAR LN IE000BW2B3J3   25,002.00 USD    693,820.39   27.751  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST INDXX FUTURE ECONOMY METALS UCITS ETF 08.01.2026 METL LN IE000UDFKE13   75,002.00 USD   2,527,111.02   33.694  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Low Duration Global Government Bond UCITS ETF 08.01.2026 FGOV LN IE00BKS2X200   33,638.00 GBP    498,781.05   17.084  ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that the Food and Drug Administration (FDA) Division of Hepatology and Nutrition has granted Kezar a Type C meeting for the first quarter to discuss the development of zetomipzomib, a novel, selective inhibitor of the immunoproteasome, in patients with autoimmune...

BOSTON--(BUSINESS WIRE)--Aurora Therapeutics today announced its official launch to transform personalized gene editing from a one-patient breakthrough into a scalable model capable of bringing therapies to millions of patients with rare diseases. The company launches with a $16 million seed financing from Menlo Ventures to create the first platform for treating rare genetic mutations that have historically been impossible to address at scale. Aurora was founded by Jennifer Doudna, Ph.D., CRISP...

OTTAWA, Ontário--(BUSINESS WIRE)--A Kinaxis® Inc. (TSX:KXS), líder global em orquestração de cadeia de suprimentos, anunciou hoje a nomeação de Razat Gaurav como CEO, em vigor a partir de 12 de janeiro de 2026, a data oficial do seu início, quando ele também começará a ser parte integrante da Diretoria da Kinaxis. "Após uma busca rigorosa, a Diretoria selecionou Razat para liderar a empresa como CEO", afirmou Bob Courteau, CEO interino e presidente da Diretoria da Kinaxis. "Os vinte e cinco ano...